All lobbying filings

MARBLE ARCH

MARBLE ARCH filed a Q4 termination report for ON DEMAND PHARMACEUTICALS on January 7, 2026, reporting $20,000 in lobbying income.

Lobbying for ON DEMAND PHARMACEUTICALS · Pharmaceutical manufacturing

All filings by MARBLE ARCH · Everything ON DEMAND PHARMACEUTICALS has reported

Filing · LD-2 quarterly report Q4 termination

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 7, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

Maryland

Representation ended

Dec 1, 2025

The registrant reported terminating its work for this client.

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Pharmacy

Issues relating to securing the domestic pharmaceutical supply chain, ensuring reliable access to essential medications, and manufacturing of high-quality generic drugs in America.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.